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In the testis, the blood–testis barrier (BTB) is constituted by spe-
cialized junctions between adjacent Sertoli cells in the seminifer-
ous epithelium near the basement membrane. Although the BTB is
one of the tightest blood–tissue barriers in the mammalian body, it
undergoes extensive restructuring at stage VIII of the seminiferous
epithelial cycle to facilitate the transit of preleptotene spermato-
cytes. Thus, meiosis and postmeiotic germ cell development take
place in the seminiferous epithelium behind the BTB. Cytokines
(e.g., TGF-β3) are known to regulate BTB dynamics by enhancing
the endocytosis of integral membrane proteins and their intracel-
lular degradation. This thus reduces the levels of proteins above
the spermatocytes in transit at the BTB, causing its disruption after
testosterone-induced new tight junction (TJ) ﬁbrils are formed be-
hind these cells. By using Sertoli cells cultured in vitro with an
established TJ permeability barrier that mimicked the BTB in vivo,
Cdc42 was shown to be a crucial regulator that mediated the TGF-
β3–induced BTB disruption. TGF-β3 was shown to activate Cdc42 to
its active GTP-bound form. However, an inactivation of Cdc42 by
overexpressing its dominant-negative mutant T17N in Sertoli cell
epithelium was shown to block the TGF-β3–induced acceleration in
protein endocytosis. Consequently, this prevented the disruption
of Sertoli cell TJ permeability barrier and redistribution of TJ pro-
teins (e.g., CAR and ZO-1) from the cell–cell interface to cell cytosol
caused by TGF-β3 on Sertoli cell BTB integrity. In su mary, Cdc42 is
a crucial regulatory component in the TGF-β3–mediated cascade of
events that leads to the disruption of the TJ ﬁbrils above the
preleptotene spermatocytes to facilitate their transit.
cytokines | GTPases | protein endocytosis | seminiferous epithelial cycle |
spermatogenesisQ:2
In mammalian testis, the seminiferous epithelium is segregatedinto the basal and apical compartments by the blood–testis
barrier (BTB), which is created by coexisting tight junction (TJ),
basal ectoplasmic specialization [ES, a testis-speciﬁc atypical
adherens junction (AJ) type], and desmosome gap junctions be-
tween adjacent Sertoli cells near the basement membrane (1, 2).
At stage VIII of the seminiferous epithelial cycle, the BTB
undergoes extensive restructuring to allow the transit of pre-
leptotene spermatocytes from the basal to the apical compart-
ment. At the same time, preleptotene spermatocytes differentiate
into leptotene and zygotene spermatocytes (3) so that meiosis and
postmeiotic germ cell development can take place in the apical
compartment behind the BTB (2). While the BTB undergoes this
cyclic restructuring throughout spermatogenesis, the immuno-
logical barrier conferred by the BTB is maintained at all time to
segregate the postmeiotic germ cell development from the host
immune system to avoid the production of antibodies against
germ cell–speciﬁc antigens that attack its own sperms. Previous
studies have shown that cytokines (e.g., TGF-β2 and TGF-β3) and
testosterone are working in concert to facilitate the transit of
spermatocytes at the BTB while maintaining the immunological
barrier (2, 4). For instance, testosterone maintains the immuno-
logical barrier by inducing de novo synthesis of junction proteins
(e.g., claudins and occludin) (5–7) as well as transcytosis of pro-
teins from other sites of the cells to promote the assembly of
“new” TJ ﬁbrils behind a spermatocyte in transit (4). Conversely,
cytokines enhance endocytosis of integral membrane proteins
above a spermatocyte in transit and target the internalized TJ ﬁ-
bril proteins for intracellular degradation (4, 8), thereby desta-
bilizing the “old” BTB ultrastructure to facilitate their transit (2).
However, the regulatory component(s) that modulates these
events, such as the TGF-β–induced enhancement in protein en-
docytosis, remains virtually unknown. Previous studies have im-
plicated the Rho family small GTPase Cdc42 in regulating protein
trafﬁcking events, such as endocytosis and exocytosis, besides its
roles as an actin cytoskeleton regulator (1). Although studies have
shown that an alteration of Cdc42 activity, such as by over-
expression of dominant-negative or constitutive-active mutant of
Cdc42, induces changes in protein trafﬁcking in cells, the up-
stream regulators that control Cdc42 activity in this process are
unknown (1). Here, we sought to examine whether TGF-β3, when
used at a concentration similar to the level at the BTB microen-
vironment in vivo (8), is an upstream physiological stimulus that
activates Cdc42, and if the activation state of Cdc42 is essential for
mediating TGF-β3–induced acceleration of protein endocytosis
at the BTB. We also examined if Cdc42 determines the extent of
endocytosed integral membrane proteins that should be recycled
and targeted to the cell surface. In short, we sought to investigate
if the TGF-β3–induced Sertoli cell BTB disruption is mediated by
Cdc42 via its effects on protein trafﬁcking.
Results
Localization of Cdc42 at the BTB Is Stage-Speciﬁc with Considerably
Diminished Expression at Stage VII to VIII of the Epithelial Cycle,
Coinciding with BTB Restructuring. To understand whether Cdc42 is
involved in regulating BTB dynamics, its localization in rat testis
was ﬁrst characterized by immunohistochemistry. Frozen testis
cross-sections from adult rats were stained with an anti-Cdc42
antibody (Fig. 1A, i–vii). This antibody speciﬁcally detected
Cdc42 by immunoblotting using lysates obtained from rat testes
and Sertoli cells (Fig. 1A, vii). Cdc42 was ubiquitously expressed
in the entire seminiferous epithelium (Fig. 1A, i). This ﬁnding is
consistent with earlier studies that show that Cdc42 regulates
various cellular processes, such as actin dynamics and cell po-
larity (1). At higher magniﬁcations, Cdc42 was found to be
prominently expressed near the basement membrane, consistent
with the localization of the BTB (Fig. 1A, ii, black arrowheads).
Furthermore, a stage-speciﬁc expression pattern was observed
(Fig. 1A, i–v). Notably, the staining of Cdc42 at the BTB in stage
V tubule was weaker compared with tubules at stage X-XIII
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(Fig. 1A, c, is a magniﬁed view of the boxed area shown in
Fig. 1A, ii). However, this diminished staining was most obvious
and drastic at stage VII-VIII (Fig. 1A, i and iv) when the BTB
undergoes extensive restructuring to facilitate the transit of
preleptotene spermatocytes. When the anti-Cdc42 antibody was
replaced with normal chicken IgY, no positive signal was ob-
served (Fig. 1A, vi) illustrating the speciﬁcity of the staining
results in Fig. 1A, i–v. To further validate the localization of
Cdc42 at the BTB, dual-labeled immunoﬂuorescence analysis
was performed to colocalize Cdc42 with a known BTB marker.
Consistently, Cdc42 (Fig. 1B, i, red) was shown to colocalize with
the basal ES marker N-cadherin (Fig. 1B, ii, green) at the BTB
(Fig. 1B, iii and iv).
Cdc42 Is Activated in Sertoli Cell Epithelium upon TGF-β3 Stimulation.
TGF-β3 is a known regulator of BTB (2), to test the possibility
that Cdc42 is a downstream mediator of TGF-β3, we ﬁrst ex-
amined if TGF-β3 affects the activation of Cdc42 in a Sertoli cell
culture system known to establish functional and structural
barrier that mimics the BTB in vivo (9). As Cdc42 switches be-
tween active (i.e., GTP-bound) and inactive (i.e., GDP-bound)
states, we performed a pull-down assay using GST-p21–binding
domain (i.e., PBD) of PAK-1 to precipitate active Cdc42 (Cdc42-
GTP). Isolated Sertoli cells were cultured in F12/DMEM for
4 d to form an intact cell epithelium before being stimulated with
4 ng/mL TGF-β3, at a concentration similar to its level at the
BTB microenvironment in vivo (8). It was found that TGF-β3
transiently activated Cdc42 at 5 and 20 min after Sertoli cells
were exposed to TGF-β3 (Fig. 2 A and B). However, prolonged
stimulation by TGF-β3 for 60 min signiﬁcantly decreased the
level of active Cdc42 versus its basal level at 0 min (Fig. 2 A and
B). In addition, the inactivation of Cdc42 at 60 min was ac-
companied by a mild but signiﬁcant decrease in the total Cdc42
(Fig. 2 A and C). Previous studies have shown that TGF-β3
disrupts the Sertoli cell TJ barrier (10). However, it is not known
if TGF-β3 disrupts the TJ barrier within 24 h after cells are ex-
posed to TGF-β3. Thus, 4 ng/mL TGF-β3 was added to the
Sertoli cell epithelium on day 4 when functional TJ had been
established (Fig. 2D). Interestingly, the TJ barrier was not dis-
rupted when the transepithelial electrical resistance (TER) as
quantiﬁed at 15 and 60 min after the addition of TGF-β3 (Fig.
2D) when Cdc42 was activated before this time at 5 to 20 min
(Fig. 2A vs. Fig. 2D). Instead, the TJ barrier was visibly disrupted
by 3 h and thereafter (Fig. 2D). These ﬁndings implicate that
Cdc42 activation maybe necessary for the subsequent effects of
TGF-β3 on the Sertoli cell TJ barrier function.
Cdc42 Is Required to Mediate TGF-β3–Induced Activation of p38
MAPK. The ﬁndings that Cdc42 is localized at the BTB (Fig. 1)
and TGF-β3 regulates its activation state (Fig. 2) implicates that
Cdc42 is a crucial mediator of TGF-β3–induced BTB disruption.
To test this hypothesis, we altered the activation state of Cdc42
by expressing full-length Cdc42 or dominant-negative Cdc42
mutant T17N in primary Sertoli cells and investigate if there is
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Fig. 1. Stage-speciﬁc expression of Cdc42 at the BTB in adult
rat testis. (A, i–v) Immunohistochemistry was performed using
frozen testis sections. The speciﬁcity of this antibody in testis
(T) and Sertoli cell (SC) were illustrated in vii. (i) Cdc42 was
localized in the seminiferous epithelium with stage-speciﬁc
expression at the BTB but it was absent in stage VIII tubules.
(ii) Magniﬁed micrograph showing Cdc42 was detected in the
Sertoli cell cytoplasm that extended toward the edge of the
tubule lumen but was predominantly localized at the BTB
(black arrowheads). (iii) Magniﬁed view of the boxed area in
b showing Cdc42 was highly expressed at the BTB with its
expression began to diminish at stage V. (iv and v) Reduced
level of Cdc42 at the BTB persisted from stage VI to VIII. At
stage VIII, Cdc42 at the BTB was virtually undetectable. (vi)
Control section in which normal chicken IgY was replaced
with the anti-Cdc42 antibody. [Scale bars: i, 100 μm; ii (applies
to vi), 40 μm; iii (applies to iv and v), 20 μm.] (B) Colocalization
of Cdc42 (red, i) with basal ES protein N-cadherin (green, ii) at
the BTB (iii). Nuclei were stained with DAPI (blue, iv). [Scale
bars: 10 μm in i (applies to ii–iv).]
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Fig. 2. TGF-β3 activates Cdc42 in Sertoli cells. (A) Sertoli cells were cultured
for 4 d, thereafter, cells were stimulatedwith TGF-β3 (4 ng/mL) for 5 to 60min.
GTP-bound Cdc42 (active form) was quantiﬁed. Equal amount of proteins
were probed with an anti-Cdc42 antibody to estimate total Cdc42, and the
same blot was stripped and probedwith an anti-actin antibody to assess equal
protein loading. TGF-β3 transiently stimulated Cdc42 at 5 and 20 min after
treatment. At 60 min, both total and active Cdc42 were signiﬁcantly de-
creased versus controls. Composite data from three experiments for Cdc42-
GTP (B) and total Cdc42 (C) are shown. Protein level at 0minwas arbitrarily set
at 1. Each bar is amean± SD; **P < 0.01. (D) Sertoli cells were cultured at 1.2 ×
106 cells/cm2 on Matrigel-coated bicameral units and the TJ barrier function
was monitored by quantifying the TER across the cell epithelium. TGF-β3
(4 ng/mL) was added to the units on day 4.5 (arrow). This experiment was
repeated three times. Each data point is a mean ± SD; **P < 0.01.
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any change in steady-state levels of integral membrane proteins at
the BTB in the presence or absence (control) of TGF-β3. The
dominant-negative mutant of Cdc42 contained a site-speciﬁc mu-
tation that converted amino acid residue 17 from Thr (T) to Asn
(N). This thereby sequesters guanine nucleotide exchange factors
to prevent endogenous Cdc42 from being activated (11). Trans-
fection was performed 2 d after Sertoli cell isolation to allow
functional TJ barrier and ultrastructures of BTB to form (12).
Overexpression of Cdc42 and T17N in primary Sertoli cells
was conﬁrmed by RT-PCR (Fig. 3A, i) and immunoblotting
(Fig. 3A, ii). An approximately 8-fold and 2.5-fold increase in
Cdc42 mRNA and protein versus vector pCIneo control were
observed, respectively. Two days after transfection, cell lysates
were harvested to examine protein levels of several BTB-associ-
ated proteins by immunoblotting. It was found that levels of several
TJ (e.g., occludin, JAM-A, CAR, and ZO-1) and basal ES proteins
(e.g., N-cadherin, α-catenin, β-catenin, and γ-catenin) remained
unaltered after overexpression of Cdc42 and T17N versus pCIneo
vector control (Fig. 3 B–D). Furthermore, when transfected cells
were treated with TGF-β3 (4 ng/mL) for 1 h, no signiﬁcant changes
in protein levels were noted (Fig. 3 B–D). Collectively, these
ﬁndings suggest that overexpression of Cdc42 or its dominant-
negativemutant T17N in Sertoli cells did not affect the steady-state
levels of integral membrane proteins at the BTB. It is noted that
TGF-β3 perturbs the Sertoli cell BTB function via p38MAPK (10,
13). Therefore, we examined the phosphorylation level of p38
MAPK after overexpression of Cdc42 or T17N in the presence or
absence of TGF-β3 (Fig. 3 E and F). Consistent with the previous
ﬁndings, TGF-β3 enhanced phosphorylation of p38 MAPK after
TGF-β3 stimulation in vector control cells. Unexpectedly, over-
expression of Cdc42 alone also activated p38 MAPK, possibly as
a result of the increased level of Cdc42 to transduce signal in the
p38 MAPK pathway. However, the level of phosphorylated-p38
MAPK was not affected by T17N overexpression. Signiﬁcantly,
inhibition of endogenous Cdc42 by T17N blocked TGF-β3–in-
duced p38 MAPK phosphorylation (Fig. 3 E and F).
Active Cdc42 Is Essential for the TGF-β3–Enhanced Protein Endocytosis
at the BTB. TGF-β3 is known to disrupt Sertoli cell BTB function
by enhancing endocytosis of integral membrane proteins at the
BTB (8). To address whether TGF-β3 induces protein in-
ternalization via activation of Cdc42, we performed an endocy-
tosis assay using Cdc42- or T17N-expressing Sertoli cells in the
presence or absence of TGF-β3 using Sertoli cells cultured for 4
d with an intact epithelium. Cell surface proteins of Sertoli cells
expressing vector control (pCIneo), Cdc42, or T17N were bio-
tinylated with approximately equal amounts of biotinylated pro-
teins (e.g., occludin and CAR) were found on the cell surface in
these cells (Fig. S1 Q:6). Sertoli cells were then incubated with or
without TGF-β3 (4 ng/mL) for 5, 20, and 60 min. Internalized
proteins were evaluated by recovering cell surface biotinylated
proteins on streptavidin beads. We quantiﬁed the rate of protein
internalization by calculating the percentage of endocytosed pro-
tein, which is deﬁned as the level of internalized proteins over
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Fig. 3. Activation of p38 MAPK by TGF-β3 is mediated by
Cdc42. (A) Sertoli cells were cultured at 0.5 × 106 cells/cm2 for
2 d to establish a functional TJ barrier before transfected
with vector control (pCIneo), full-length Cdc42 (Cdc42), or
dominant-negative mutant of Cdc42 (T17N). (i) Total RNA was
extracted 12 h posttransfection and treated with DNase I to
remove any possible genomic DNA contamination, and the
expression level of Cdc42 mRNA was monitored by RT-PCR with
S16 served as a loading control (Upper). (ii) Immunoblotting
was performed 2 d after transfection to assess the increase in
Cdc42 and T17N protein levels. Lower panels in a and b are
composite results from three experiments. (B) Protein lysates
were harvested 2 d after transfection. Before termination, cells
were treated with or without TGF-β3 (4 ng/mL) for 60 min.
Steady-state levels of BTB-associated proteins were then
assessed by immunoblotting. (E) Phosphorylation of p38 MAPK
was quantiﬁed by immunoblotting using an anti–phospho-p38
antibody. Addition of TGF-β3 in vector control (pCIneo) cells or
overexpression of Cdc42 alone resulted in phosphorylation of
p38 MAPK. Activation of p38 MAPK was Cdc42-dependent as
overexpression of the dominant-negative mutant of T17N
prevented its activation induced by TGF-β3. Total p38 MAPK
level remained unchanged in all groups. (C, D, and F) Bar
graphs (mean ± SD) show composite results of three experi-
ments. Cdc42 mRNA (A, Lower) and protein (C, D, and F) levels
were normalized against S16 and actin, respectively, with the
mRNA and protein level from cells transfected with pCIneo
(vector alone) arbitrarily set at 1; **P < 0.01.
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total cell surface proteins that were biotinylated without stripping.
As shown in Fig. 4 A, B, and E, Sertoli cells expressing full-length
Cdc42 displayed an increase in endocytosis of occludin and CAR
versus vector control. In contrast, expression of T17N in Sertoli
cells did not change the rate of endocytosis signiﬁcantly versus
control cells (Fig. 4 A, B, and E). Similar to the previously pub-
lished results (8), TGF-β3 promoted endocytosis of occludin and
CAR (Fig. 4 A, C, and F). Besides, we found that by over-
expressing Cdc42 and stimulating the cells with TGF-β3, it has an
additive effect on enhancing protein endocytosis (Fig. 4 A, D, and
G). Importantly, Sertoli cells lacking active Cdc42, by expressing
dominant-negative mutant T17N, was shown to eliminate the
stimulatory effect of TGF-β3 on protein endocytosis (Fig. 4 A, D,
and G). Collectively, these data demonstratedQ:7 that the disruptive
effects of TGF-β3 on BTB dynamics via an increase in protein
endocytosis at the BTB is mediated by Cdc42. Furthermore, these
ﬁndings also illustrated that, although protein endocytosis at the
Sertoli cell BTB per se under basal condition is not entirely de-
pendent on Cdc42, the TGF-β3–induced protein endocytosis is
dependent on Cdc42.
Protein Recycling to the Cell Surface Is Impaired by an Inactivation of
Cdc42. The amount of proteins that remains at the intercellular
junctions is the net result of protein endocytosis, recycling,
transcytosis, and intracellular degradation. Thus, we next in-
vestigated if Cdc42 affects recycling of endocytosed proteins to
cell surface. Cell surface proteins were biotinylated and cells were
incubated at 18 °C for 2 h to allow accumulation of endocytosed
proteins in early or sorting endosomes (14). Biotin that remained
on cell surface proteins that were not endocytosed was removed
by 2-mercaptoethane sulfonate (MESNA) stripping buffer. Bio-
tinylated proteins that were internalized into cell cytosol were
allowed to recycle back to the plasma membrane for 1 h, which
was subsequently extracted to track the amount of recycled bio-
tinylated proteins on the cell surface. Fig. S2 illustrates that an
equal amount of protein was used the recycling assay shown in
Fig. 5. In line with the previously published results, TGF-β3 im-
paired targeting of endocytosed proteins back to the cell surface.
Instead, they underwent endosome-mediated protein degradation
(4) (Fig. 5A), which eventually led to a disruption of Sertoli cell
TJ barrier (Fig. 5A and Fig. 2D). However, in this study, it was
shown that overexpression of T17N alone also inhibited protein
recycling but to a lesser extent versus control cells treated with
TGF-β3 (T17N vs. pCIneo+TGF-β3; Fig. 5A). Interestingly, it is
noted that there was no signiﬁcant change in recycling of CAR
when T17N-expressing cells were treated with TGF-β3.
Inactivation of Cdc42 Blocks TGF-β3–Induced Disruption of Cell Junctions
at theBTB.We next characterized if an inactivation of Cdc42 would
lead to any phenotypic changes in the Sertoli cell TJ barrier and
protein distribution at the cell–cell interface (Fig. S3). Over-
expression of dominant-negative T17N was performed on day 2 by
transfecting Sertoli cells with an established TJ barrier. On day
4.5, 4 ng/mL TGF-β3 was added in both the apical and basal
compartments of the bicameral units for 24 h (Fig. 6A). In vector
control cells, TGF-β3 signiﬁcantly perturbed the TJ barrier by 3 h
which persisted until the end of the experiment. Conversely, T17N
expression prevented TGF-β3–induced TJ barrier disruption (Fig.
6A). We next determined if these changes in TJ barrier disruption
would be reﬂected by an alteration in the localization of junction
proteins at the cell–cell interface. Transfected cells were denoted
by vectors that were ﬂuorescently labeled by Cy3 (Fig. 6B and C,
red). CAR (Fig. 6B, green) and ZO-1 (Fig. 6C, green) was lo-
calized at the cell–cell interface in control cells without treatment
of TGF-β3 that formed an almost undisrupted barrier. However,
cells that were treated with TGF-β3 (4 ng/mL) displayed a dis-
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Fig. 4. TGF-β3–mediated acceleration of protein endocytosis at the BTB
requires active Cdc42. (A) Sertoli cells expressing vector control (pCIneo),
Cdc42, or dominant-negative Cdc42 (T17N) were used for endocytosis assay
2 d after transfection. Cells were biotinylated at 4 °C and incubated in the
presence or absence of TGF-β3 (4 ng/mL) for 0, 5, 20, or 60 min at 35 °C to
allow protein endocytosis. At speciﬁed time points, biotin on cell surface
proteins that were not internalized were stripped. Cell lysates were har-
vested in RIPA lysis buffer. Biotinylated proteins that were endocytosed were
recovered by using NeutrAvidin beads for immunoblotting. Half of the total
cell surface biotinylated proteins, without stripping with MESNA buffer,
were used to estimate the percentage of endocytosed protein. The blots for
occludin and CAR shown herein are representative of three experiments.
Actin served as a loading control. B–D and E–G are the corresponding data
for occludin and CAR. (B and E) Results expressed as the percentage of
endocytosed protein normalized against total cell surface biotinylated pro-
tein. Transient overexpression of Cdc42 enhanced protein endocytosis
whereas overexpression of T17N did not affect kinetics of protein in-
ternalization versus vector control, illustrating that Cdc42 facilitated but was
not essential for protein endocytosis at the BTB under normal physiological
conditions. (C and F) Addition of TGF-β3 increased the rate of protein en-
docytosis versus vector control. Each time point is mean ± SD; **P < 0.01
(pCIneo vs. Cdc42, T17N or pCIneo+TGF-β3). (D and G) Treatment of Sertoli
cells overexpressing Cdc42 with TGF-β3 further enhanced endocytosis.
However, overexpression of T17N abolished TGF-β3–induced enhancement
of protein endocytosis. Each time point is a mean ± SD; **P < 0.01 (Cdc42 vs.
Cdc42+TGF-β3); n.s., no signiﬁcant change (T17N vs. T17N+TGF-β3).
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However, inactivation of Cdc42 neither blocked nor potentiated TGF-β3–
induced disruption of protein recycling. (B) Composite data of A is shown.
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ruption of CAR and ZO-1 staining at the Sertoli cell junctions
(Fig. 6B and C). In cells with Cdc42 overexpression, a mild dis-
ruption of CAR localization (Fig. 6B) at the cell junction was
noted, and more ZO-1 also redistributed near the cell surface
(yellow arrowheads in Fig. 6B) to cytosol (white arrowheads in Fig.
6B). These ﬁndings are consistent with the results indicating that
both TGF-β3 treatment and Cdc42 overexpression resulted in
enhanced endocytosis as shown in Fig. 4 A–G. However, both
CAR and ZO-1 remained at the cell–cell interface in Sertoli cells
overexpressing T17N (Fig. 6 B and C and Fig. S3). In agreement
with the additive effect in endocytosis by treating Cdc42-express-
ing cells with TGF-β3, a more severe disruption in CAR and ZO-1
localization was noted (Fig. 6 B and C, green). Based on results
shown in Fig. 4 A and D–G, TGF-β3–induced enhancement in
endocytosis was abolished when Cdc42 was inactivated. This
ﬁnding was conﬁrmed by data shown in Fig. 6 A and B in which
overexpression of T17N in the epithelium would render these cells
nonresponsive to the disruptive effects of TGF-β3. For instance,
the disruptive effect of TGF-β3 in redistributing CAR and ZO-1
from the cell surface to cytosol was blocked when Cdc42 was
inactivated (Fig. 6 B and C).
Discussion
TGF-β3–Accelerated Protein Endocytosis That Leads to BTB Disruption
Is Mediated by Cdc42. Cdc42 was shown to be a downstream ef-
fector necessary for the TGF-β3–induced BTB restructuring.
TGF-β3 appears to exert its effects by ﬁrst activating Cdc42 to its
GTP-bound form, which in turn enhances protein endocytosis at
the BTB to disrupt the TJ barrier. Although overexpression of
Cdc42 in Sertoli cells facilitates protein endocytosis, its in-
activation in Sertoli cells, such as by overexpressing T17N, did not
affect the kinetics of protein endocytosis at the BTB or the dis-
tribution of CAR and ZO-1 at the cell surface as reported herein.
This illustrates that the function of Cdc42 on endocytosis under
normal physiological conditions can be superseded by other
GTPases, as several GTPases are involved in endocytic vesicle-
mediated protein trafﬁcking (15, 16). However, Cdc42 is abso-
lutely needed for TGF-β3–mediated Sertoli cell BTB disruption
and this effect cannot be superseded by other GTPases, as sup-
ported by several observations. First, Cdc42 was activated by
TGF-β3 preceding the TJ barrier disruption. Second, inactivation
of Cdc42 via an overexpression of T17N in Sertoli cells would
render a loss of response of the cell epithelium to TGF-β3–
induced acceleration in protein endocytosis. Third, perhaps most
importantly, an inactivation of Cdc42 would lead to a loss of re-
sponse of the Sertoli cells to the disruptive effects of TGF-β3
regarding the TJ barrier function. These ﬁndings are further
supported by immunoﬂuorescence analysis, which showed that
TGF-β3 was effective to induce relocation of CAR and ZO-1
from the cell–cell interface to cytosol, but it failed to induce
similar redistribution of CAR in Sertoli cells when Cdc42 was
inactivated. Collectively, these data demonstrate unequivocally
the pivotal role of Cdc42 in mediating the regulatory function of
TGF-β3 in BTB dynamics. However, it is of interest to note that
the expression of Cdc42 in the seminiferous epithelium as dem-
onstrated by immunohistochemistry using an antibody against
total Cdc42 is stage-stage, where its expression at the BTB is
lowest at stage VIII whereas TGF-β3 expression at this site is
highest at this stage (13). If Cdc42 is so crucial to TGF-β3 action
at stage VIII, why would its expression level be reduced at the
BTB at this stage? We offer the following explanation. The an-
tibody used in our study stained total Cdc42, yet most of the
Cdc42 at the BTB at this stage would have been activated by
TGF-β3, as shown in Fig. 2A, when its expression was highest at
the BTB site at stage VIII as reported earlier (13). As activated
Cdc42 would have a different antigenic conﬁguration, this makes
it possibly unrecognizable by the anti–total Cdc42 antibody. These
ﬁndings are analogous to an earlier report illustrating total FAK is
localized mostly at the BTB, but its active phosphorylated forms
(e.g., p-FAK-Tyr397 and p-FAK-Tyr576) are restricted to the apical
ES (17), where the anti–total FAK failed to detect these two
activated forms at this site. Additionally, germ cells may regulate
the expression and/or the activation of Sertoli cell Cdc42 in the
seminiferous epithelium microenvironment, such as the BTB.
Cdc42 Is Not Involved in TGF-β3–Mediated Protein Recycling Events.
In the present study, Cdc42 was shown to be involved in protein
recycling, analogous to earlier studies in MDCK cells reporting
that a deletion (18) or inactivation of Cdc42 (19) would impede
protein recycling back to the cell surface. However, Cdc42 is not
essential in basal and TGF-β3–mediated protein recycling. For
instance, cell–cell junctions remain intact in T17N-expressing
cells despite a decrease in recycling of CAR back to the cell
surface. Furthermore, when control cells were treated with TGF-
β3, a disruption of CAR and ZO-1 localization was observed
when there is an increase in endocytosis and a decrease in pro-
tein recycling. This conclusion is further strengthened from the
immunoﬂuorescence staining and TER measurement data,
which show that overexpression of T17N is able to reverse the
disruptive effects of TGF-β3 on the TJ barrier by blocking the
increase in TGF-β3–mediated endocytosis. These results collec-
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Fig. 6. Sertoli cell junction disruption induced by TGF-β3 is blocked by in-
activation of Cdc42. (A) Sertoli cells were cultured at 1.2 × 106 cells/cm2 on
bicameral units and transfected with vector control pCIneo or T17N on day 2
after plating; 2.5 d thereafter (i.e., on day 4.5), cells were treated with or
without TGF-β3 (4 ng/mL) and the TJ barrier function was monitored by TER
measurement. Expression of T17N alone did not result in change in TER
versus vector control (pCIneo). Addition of TGF-β3 in vector control cells
resulted in a signiﬁcant decrease in TER, illustrating TJ barrier disruption.
Conversely, overexpression of T17N blocked the disruptive effect of TGF-β3
on the TJ barrier. (B and C) Sertoli cells transfected with vector control
(pCIneo), Cdc42, or T17N were treated with or without 4 ng/mL of TGF-β3 for
60 min. Transfected cells were tracked by ﬂuorescently labeling plasmids
with Cy3 (red). Cells were ﬁxed and stained with either an anti-CAR antibody
(green) (B) or an anti–ZO-1 antibody (green) (C). Nuclei were visualized
by DAPI (blue). Overexpression of Cdc42 caused a mild redistribution of CAR
(B) and ZO-1 (C) from the Sertoli–Sertoli cell interface to cytosol versus
pCIneo. Treatment of control cells with TGF-β3 disrupted the localization of
CAR (B) and ZO-1 (C) at the cell–cell interface in both control and Cdc42-
overexpressed cells, causing them to relocate from the cell surface (yellow
arrowhead) to cytosol (white arrowhead). Whereas overexpression of Cdc42
worsened junction damage induced by TGF-β3, inactivation of Cdc42 by
overexpressing T17N blocked the TGF-β3–induced junction disruption, con-
ﬁrming results in A.
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tively reveal that the role of Cdc42 on mediating TGF-β3–
induced protein endocytosis is more profound and is able to
supersede its effect on recycling of proteins to cell surface.
Conversely, if protein recycling at the BTB is dependent entirely
on Cdc42, the TJ barrier function would have been disrupted
after overexpression of T17N in Sertoli cells because of the im-
pairment in protein recycling. These ﬁndings are consistent with
earlier studies that show an inactivation of Cdc42 did not result
in morphological changes in TJ ﬁbrils in MDCK cells (19, 20). It
is likely that, although Cdc42 activity is needed for protein
recycling at the BTB, other small GTPases, such as Rab proteins
(e.g., Rab13) (21, 22) play a more dominant role on protein
recycling, and TGF-β3 can also mediate its effects on recycling
via one of these other GTPases.
Cdc42 Are Working with Polarity Proteins to Regulate BTB Dynamics.
During the inﬁltration of Neisseria meningitidis across the blood–
brain barrier that causes meningitis, an activation of Cdc42 was
detected that induced protein endocytosis in the microvessel
endothelium to increase TJ permeability to facilitate the bacte-
rial entry (23). To prevent hemorrhage, the bacterial pili also
activated Cdc42 behind their entry site to recruit polarity com-
plex Par3/Par6/aPKC to reestablish the endothelial barrier by
relocating the endocytosed TJ and AJ proteins via transcytosis to
the site (23). In fact, Cdc42 is known to be involved in targeting
of proteins to the basolateral domain of epithelial cells (19, 24).
Together with the previously published results in which Par6 and
14–3-3 (also known as Par5) were shown to be involved in
endocytic vesicle-mediated protein trafﬁcking at the BTB (25), it
is likely that Cdc42 is working in concert with Par6 and 14–3-3 to
play a dual role in regulating BTB dynamics. First, Cdc42 facil-
itates TGF-β3–ehanced endocytosis to disrupt “old” TJ-ﬁbrils
above the migrating spermatocytes. Second, it also helps to tar-
get the endocytosed proteins to the “new” BTB site below the
spermatocytes via transcytosis, likely working with Par6 and 14–
3-3. This thus maintains the BTB integrity during the transit
of spermatocytes.
Materials and Methods
Animals and Antibodies. The use of Sprague-Dawley rats was approved by the
Rockefeller University Animal Care and Use Committee (protocols 06018 and
09016). Antibodies used in this study are listed in Table S1.
General Methods. Primary Sertoli cell cultures, DNA transfection, cell staining,
preparation of cDNA constructs, Cdc42 activation assay, immunohisto-
chemistry, ﬂuorescence microscopy, TJ barrier function assessment, and
statistical analysis are described in SI Materials and Methods.
Endocytosis Assay. Endocytosis assay was performed as described (4, 25). Cell
lysates were harvested in RIPA buffer (50 mM Tris/HCl, 150 mM NaCl, 5 mM
EGTA, 0.2% SDS, 1% Triton X-100, 1% sodium deoxycholate, and 2 mM
N-ethylmaleimide, pH 8), with 1 μg/mL aprotinin, 1 μg/mL leupeptin, 2 mM
PMSF, and 15 μL/mL each of phosphatase inhibitor mixtures 1 and 2 (Sigma).
Biotinylated proteins were recovered by Ultralink Immobilized NeutrAvidin
Plus beads (Pierce) and subjected to SDS/PAGE and immunoblotting.
Recycling Assay. Cell surface proteins were biotinylated at 4 °C as described
(4). Cells were then incubated at 18 °C for 2 h to allow internalization and
accumulation of biotinylated proteins in early or sorting endosomes (14).
Biotinylated proteins that were not endocytosed were stripped by 50 mM
2-mercaptoethanesulfonate MESNA buffer (15). F12/DMEM with or without
TGF-β3 (4 ng/mL) was added for 1 h at 35 °C and plasma membrane was
extracted. In brief, cells were scraped from 100-mm plates in 250 mM su-
crose, 20 mM Tris-HCl, 2 mM EGTA, pH 7.5, freshly supplemented with
protease and phosphatase inhibitors (lysis buffer). Cells were sonciated and
unbroken cells and nuclei were removed by centrifugation at 3,000 × g for
5 min. Postnuclei supernatant was centrifuged at 17,000 × g for 20 min, and
the pellet was resuspended in 100 μL of lysis buffer and overlaid on 1 mL of
1.12 M sucrose solution. Ultracentrifugation was performed at 100,000 × g
for 1 h and the top layer of the sucrose cushion was enriched with plasma
membrane. Subsequently, the top layer was collected and centrifuged at
40,000 × g for 30 min, and the pellet (plasma membrane) was dissolved in
RIPA buffer for afﬁnity precipitation by NeutrAvidin Plus beads.
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SI Materials and Methods
Primary Sertoli Cell Cultures, DNA Transfection, and Cell Staining.
Primary Sertoli cells were isolated from 20-d-old rat testes as
described (1, 2). Cells were plated at a density of 0.5 × 106 cells/
cm2 on Matrigel-coated dishes (Matrigel:F12/DMEM at 1:7, vol/
vol). Two days after isolation, cells were transfected with pCIneo
vector control, full-length Cdc42, or dominant-negative mutant
T17N plasmid using Effectene transfection reagent (Qiagen).
The ratio of DNA to enhancer was 1:8 μL whereas the ratio of
DNA to Effectene was at 1 μg:15 μL. A total of 1 μg (12-well
plate for cell lysates), 2 μg (6-well plate for endocytosis assay), or
10 μg (100-mm plate for recycling assay) of DNA was trans-
fected. Two days after transfection, cells were treated with or
without TGF-β3 (4 ng/mL; Calbiochem) for speciﬁed time points
and harvested in IP lysis buffer (50 mM Tris, 150 mM NaCl, 1%
Nonidet P-40, 2 mM EGTA, 2 mM ethylmaleimide, 10% glyc-
erol, pH 7.4), freshly supplemented with 1 μg/mL aprotinin, 1 μg/
mL leupeptin, 2 mM PMSF, and 15 μL/mL each of phosphatase
inhibitor mixtures 1 and 2 (Sigma) or cells were subjected to
endocytosis or recycling assay. For cell staining, cells were plated
at a density of 0.05 × 106 cells/cm2 on Matrigel-coated coverslips
placed in 12-well plate. Transfection was performed as described
earlier except that a total of 0.08 μg of ﬂuorescently labeled
DNA (Cy3 LabelIT tracker intracellular nucleic acid localization
kit; Mirus) was used. Cells were treated with or without TGF-β3
(4 ng/mL) for 1 h before used for immunoﬂuorescence staining.
Preparation of Cdc42 and T17N Mutant cDNA Constructs. Rat full-
length Cdc42 (NM_171994) was ampliﬁed using the sense primer
5′-CACTCGAGATGCAGACAATTAAGTGTGTTGTTGTTG-3′
and antisense primer 5′-CAGCGGCCGCTCATAGCAGCACA-
CACCTGC-3′ from testis total cDNAs. AccuPrime Taq DNA
polymerase (Invitrogen) was used for the PCR. The PCR product
was subsequently cloned into the XhoI and NotI sites in the pCI-
neo vector (Promega). To generate dominant-negative mutant of
Cdc42 (T17N), site-directed mutation was performed using the
QuikChange XL site-directed mutagenesis kit (Stratagene) ac-
cording to the manufacturer’s protocols. The full-length Cdc42
in pCIneo was used as the template, with the mutagenic primers
5′-GGTGATGGTGCTGTTGGTAAAAACTGTCTCCTGAT-
ATCC-3′ (sense) and 5′-GGATATCAGGAGACAGTTTTTA-
CCAACAGCACCATCACC-3′ (antisense). The underlined se-
quences indicated the mutations introduced, which altered
amino acid residue 17 from the N terminus of Cdc42 from Thr
(T) to Asn (N). The authenticity of the plasmids was conﬁrmed
by direct DNA sequencing at Genewiz. All plasmids were pre-
pared using the HiSpeed Plasmid Midi kit (Qiagen).
Cdc42 Activation Assay.To quantify activated Cdc42 (Cdc42-GTP),
primary Sertoli cells were plated at a density of 0.5 × 106 cells/cm2
on a Matrigel-coated 60-mm dish. Four days thereafter, Sertoli
cells were stimulated with or without TGF-β3 (4 ng/mL) for
speciﬁed time points. Cell lysates were harvested in magnesium
lysis/wash buffer (Upstate) freshly supplemented with 10% glyc-
erol, 10 μg/mL aprotinin, and 10 μg/mL leupepetin (MLB buffer).
Active Cdc42 was pulled down by recombinant protein corre-
sponding to the p21-binding domain of PAK-1 conjugated to
agarose beads (Upstate). Precipitated complex was washed three
times by MLB buffer and active Cdc42 was visualized by immu-
noblotting using a monoclonal anti-Cdc42 antibody (Upstate).
Immunohistochemistry and Fluorescence Microscopy. Frozen testis
cross-sections ﬁxed in Bouin ﬁxative were used for immunohisto-
chemistry (3) with the antibody dilutions listed in Table S1. Biotin-
conjugated anti–chicken IgY secondary antibody (Abcam) was
used before detecting signal with Histostain-SP kit (Zymed Labo-
ratories). Normal chicken IgY (Santa Cruz Biotechnology) served
as control. For immunoﬂuorescence microscopy, testis sections
were ﬁxed in 4% paraformaldehyde, followed by permeabilization
with 0.2% Triton X-100. Sections were mounted in Prolong Gold
antifade reagentwithDAPI (Invitrogen). All images were acquired
with an Olympus BX40 ﬂuorescence microscope and an Olympus
DP70 12.5MPa digital camera using the QCapture software
(Quantitative Imaging), with the TIFF images imported to Pho-
toShop (version 10.0.1; Adobe Systems) for overlays and analysis.
Assessment of TJ Permeability Barrier. Sertoli cells were plated on
Matrigel-coated bicameral units (Millipore) at 1.2 × 106 cells/cm2
in triplicate, and the TJ barrier was monitored by TER across the
cell epithelium using a Millicell electrical resistance system
(Millipore). TGF-β3 (4 ng/mL) was added to both the apical and
basal compartments. For overexpression experiments, 0.5 μg
DNA was transfected into Sertoli cells in the apical compartment.
Statistical Analysis. Data from treatment groups were compared
with the corresponding controls by one-way ANOVA followed by
Dunnett test using the GBSTAT Statistical Analysis software
package (Dynamic Microsystems). For protein endocytosis ex-
periments, two-way ANOVA followed by Newman-Keuls test was
performed. All in vitro experiments were repeated at least three to
four times using different batches of Sertoli cells.
SI Discussion
How Does the BTB Maintain Its Integrity During the Transit of Pri-
mary Spermatocytes? The BTB is one of the tightest blood–tissue
barriers (4). Unlike all other blood–tissue barriers (e.g., the
blood–brain barrier), which are constituted by TJ between en-
dothelial cells of the blood capillaries, the BTB is contributed by
coexisting TJ, basal ES, and desmosome-gap junction between
adjacent Sertoli cells near the basement membrane (5, 6). How-
ever, it remains unknown how the BTB attains its plasticity to
allow preleptotene spermatocytes in clones and connected by
cytoplasmic bridges to traverse the barrier at stage VIII of the
epithelial cycle while maintaining immunological barrier integrity
(7). Based on recent ﬁndings, a hypothetical model has been
emerged (4) in which “new” TJ ﬁbrils form behind the sperma-
tocytes in transit to create a “new” BTB before “old” TJ ﬁbrils
above the spermatocytes are dissolved. This is mediated by tes-
tosterone and/or estrogens which promote the assembly of “new”
TJ ﬁbrils by de novo synthesis of junction proteins (8–11) and/or
transcytosis (12) of proteins from intercellular junction sites
above the transiting spermatocytes. “Old” TJ-ﬁbrils above the
spermatocytes will then be “dissolved” under the inﬂuence of
cytokines (e.g., TGF-β3), which increase the clathrin-mediated
endocytosis of the integral membrane proteins (12, 13). In-
ternalized proteins will be targeted to the “new” BTB site by
testosterone or undergone endosome-mediated degradation (12).
This thus allows the transit of spermatocytes at the BTB while
maintaining the immunological barrier. However, the mechanism
(s) that control these complex protein trafﬁcking events are just
beginning to be unveiled. Here, we have demonstrated that the
TGF-β3–induced disruption of the “old” BTB above the sper-
matocytes in transit is facilitated by an increase in protein endo-
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cytosis, but this process is tightly regulated by Cdc42. As Cdc42 is
also detected at the apical ES, it is likely that it also plays a role in
modulation spermiation as this event and BTB restructuring take
place simultaneously at the opposite ends of the epithelium at
stage VIII of the epithelial cycle. As such, Cdc42 plausibly serves
as the molecular “switch” to coordinate these events.
Transient Activation of Sertoli Cell Cdc42 in Response to TGF-β3
Treatment. The transient activation of Cdc42 in response to
TGF-β3 as shown in Fig. 2 in the main text is intriguing. How-
ever, it is noted that, in addition to this observation having been
seen repeatedly in multiple experiments using different batches
of Sertoli cells, this ﬁnding is consistent with data in the litera-
ture. For instance, Edlund et al. reported that after treatment of
prostate cancer cell line PC-3U with TGF-β and cadmium
chloride, there was an activation of Cdc42 soon after treatment
at 5 to 15 min (14). However, further treatment up to 2 h re-
sulted in an inactivation of Cdc42. Interestingly, a second wave
of activation was observed at 6 h posttreatment. In our study as
reported herein, we did not investigate if Cdc42 was activated
after Sertoli cells were treated with TGF-β for as long as several
hours. However, we speculate that activation of Cdc42 is
a transient but prerequisite event to facilitate protein endocy-
tosis mediated by TGF-β3. This is consistent with the normal
mode of action of small GTPases whereby they are activated
transiently to transduce signals to downstream effectors, to be
followed by their rapid inactivation to prevent unwanted stimu-
lation of other signaling pathways. Therefore, even though the
phenotypic changes (such as redistribution of junction proteins
from the cell–cell interface to cell cytosol, and a signiﬁcant de-
cline in Sertoli cell TJ permeability barrier when quantiﬁed by
TER across the cell epithelium) were observed after the acti-
vation of Cdc42, it is physiologically signiﬁcant. In addition,
overexpression of dominant negative form of Cdc42 reversed the
disruptive effects caused by TGF-β3, which provides direct evi-
dence indicating activation of Cdc42 is involved in mediating the
damaging effects by TGF-β on the Sertoli cell BTB.
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Fig. S1. Analysis of total biotinylated proteins on cell surface of Sertoli cells. (A) Proteins at the cell surface of Sertoli cells expressing vector control (pCIneo),
Cdc42, or dominant-negative Cdc42 (T17N) were biotinylated. Biotinylated proteins were recovered by NeutrAvidin in the pull-down assay and occludin or CAR
was visualized by immunoblotting using corresponding speciﬁc antibody. Equal amount of occludin and CAR were observed at the cell surface of control,
Cdc42, or T17N expressing cells. (B) Composite results from three independent experiments were shown that illustrate an insigniﬁcant change in total cell
surface biotinylated protein levels of occludin and CAR.
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Fig. S2. An analysis to verify that similar amount of protein was used in recycling assay. Silver nitrate–stained gel illustrating equal amount of protein was
used in recycling assay. Recycling assay and plasma membrane extraction was performed as described in Materials and Methods. To illustrate that equal
amount of protein was used in the afﬁnity precipitation step to quantify the levels of selected proteins that were recycled to cell surface, proteins were
resolved by SDS/PAGE and the gel was stained with silver nitrate as described (15) (A). (B) To further conﬁrm that equal amount of plasma membrane proteins
was used for afﬁnity precipitation, immunoblotting was performed using a plasma membrane marker sodium/potassium ATPase α1 (Na+/K+-ATPase α1). Lower
panel is a composite result of two independent experiments by immunoblotting, such as the one shown in the upper panel.
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Fig. S3. Dual-labeled immunoﬂuorescence analysis to assess cellular distribution of CAR and an endocytic vesicle marker early endosome antigen–1 (EEA-1).
Sertoli cells were transfected with vector control (pCIneo), Cdc42, or T17N on day 2 after isolation after an intact cell epithelium was established with
a functional TJ permeability barrier. Two days after transfection, cells were treated with or without 4 ng/mL of TGF-β3 for 60 min. Thereafter, cells were ﬁxed
with 4% paraformaldehyde and stained with an anti-CAR antibody (green) and an anti–EEA-1 antibody (red). Nuclei were visualized by DAPI (blue). Consistent
with Fig. 6 B and C in the main text, overexpression of Cdc42 caused a redistribution of CAR from the cell–cell interface to cytosol compared with vector control
pCIneo. Interestingly, the redistributed CAR protein colocalized with EEA-1 (white arrowheads), indicating that the internalized CAR protein was sorted into
the early endosome. In addition, similar to the previous results (13), treatment of Sertoli cells with TGF-β3 disrupted the localization of CAR at the cell–cell
interface. Concomitantly, internalized CAR protein colocalized with EEA-1. This change was observed in both control and Cdc42 overexpressed cells, but not
Sertoli cells that expressed T17N.
Table S1. Antibodies used for different experiments in this report
Antibody (host animal) Vendor Catalog no. Application/working dilution Fixation
Goat anti-actin Santa Cruz Biotechnology sc-1616 WB (1:200) —
Mouse anti-occludin Zymed Laboratories 33–1,500 IF (1:50) —
Mouse anti-γ-catenin BD Transduction Laboratories 610254 WB (1:1,000) IF (1:75) —
Rabbit anti-occludin Zymed Laboratories 71–1500 WB (1:150) —
Rabbit anti-ZO-1 Zymed Laboratories 61–7300 WB (1:150) 4% PFA (IF)
Rabbit anti-N-cadherin Santa Cruz Biotechnology sc-7939 WB (1:200) IF (1:50) 4% PFA (IF)
Rabbit anti-α-catenin Santa Cruz Biotechnology sc-7894 WB (1:200) IF (1:50) —
Rabbit anti-β-catenin Santa Cruz Biotechnology sc-7199 WB (1:200) IF (1:50) —
Rabbit anti-γ-catenin Santa Cruz Biotechnology sc-7900 WB (1:200) —
Chicken anti-Cdc42 Abcam ab17437 WB (1:3,000) IHC
(1:100) IF (1:75)
Bouin ﬁxative (IHC)
4% PFA (IF)
Mouse anti-Cdc42 Upstate Biotechnology 05–542 WB (1:250) —
Rabbit anti-CAR Santa Cruz Biotechnology sc-15405 WB (1:200) IF (1:50) Methanol (IF) 4% PFA (IF)
Mouse anti-EEA-1 BD Transduction Laboratories 610456 IF (1:50) 4% PFA (IF)
Mouse anti-Na+/K+ -ATPase α1 Abcam ab7671 WB (1:2,500) —
IF, immunoﬂuorescent microscopy; IHC, immunohistochemistry; IP, immunoprecipitation; PFA, paraformaldehyde; WB, Western blotting.
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